MHD FIRAS ZAKARIA: Open Payments
NPI 1912218272 · PALOS HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$989 in 47 payments from 16 companies in 2025. Trend: 2023 $2,369 · 2024 $1,975 · 2025 $989
Food & beverage: $989
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 14 | $218 |
| Novo Nordisk Inc | 7 | $160 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| PFIZER INC. | 4 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $71 |
| Exact Sciences Corporation | 2 | $55 |
| Merck Sharp & Dohme LLC | 3 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| SANOFI-AVENTIS U.S. LLC | 1 | $36 |
| Lilly USA, LLC | 1 | $32 |
Products named: TRELEGY ELLIPTA, REXULTI, Ozempic, Kerendia, The Cologuard Plus Collection Kit, NURTEC ODT, VERQUVO, Rybelsus.
Industry payments across IL — which companies pay providers there.
